Shares of Castlight Health Inc (NYSE:CSLT) have earned a consensus recommendation of “Hold” from the seven brokerages that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $5.20.
Separately, Zacks Investment Research cut Castlight Health from a “buy” rating to a “hold” rating in a research note on Friday, March 1st.
In related news, EVP Neeraj Gupta sold 8,738 shares of Castlight Health stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $3.61, for a total transaction of $31,544.18. Following the sale, the executive vice president now directly owns 275,255 shares in the company, valued at $993,670.55. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO John C. Doyle sold 22,956 shares of Castlight Health stock in a transaction dated Wednesday, February 20th. The shares were sold at an average price of $3.13, for a total transaction of $71,852.28. Following the sale, the chief executive officer now owns 276,773 shares in the company, valued at $866,299.49. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 86,106 shares of company stock worth $287,154. Company insiders own 17.37% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Amalgamated Bank bought a new stake in Castlight Health in the fourth quarter worth about $25,000. Parametric Portfolio Associates LLC bought a new stake in Castlight Health in the first quarter worth about $63,000. BNP Paribas Arbitrage SA raised its position in Castlight Health by 847.1% in the first quarter. BNP Paribas Arbitrage SA now owns 18,174 shares of the software maker’s stock worth $68,000 after acquiring an additional 16,255 shares in the last quarter. Virtu Financial LLC bought a new stake in Castlight Health in the first quarter worth about $77,000. Finally, Two Sigma Investments LP bought a new stake in Castlight Health in the fourth quarter worth about $51,000. Institutional investors and hedge funds own 49.30% of the company’s stock.
CSLT stock traded down $0.13 during mid-day trading on Thursday, reaching $3.42. The company had a trading volume of 716,312 shares, compared to its average volume of 399,746. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.87 and a current ratio of 1.87. The stock has a market capitalization of $492.34 million, a price-to-earnings ratio of -21.38 and a beta of 1.56. Castlight Health has a one year low of $1.86 and a one year high of $5.95.
Castlight Health (NYSE:CSLT) last posted its earnings results on Thursday, February 28th. The software maker reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.02. The company had revenue of $42.10 million for the quarter, compared to analysts’ expectations of $40.61 million. Castlight Health had a negative return on equity of 11.47% and a negative net margin of 23.04%. As a group, analysts predict that Castlight Health will post -0.12 EPS for the current fiscal year.
Castlight Health Company Profile
Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers implementation, user and customer support, and marketplace services.
See Also: Economic Reports
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.